Stock ORT B ORTOMA AB
Add to a list
To use this feature you must be a member
Log inSign up

Financials Ortoma AB

Equities

ORT B

SE0005676103

Advanced Medical Equipment & Technology

Delayed Nasdaq Stockholm
Other stock markets
 02:47:14 07/06/2024 pm IST 		5-day change 1st Jan Change
7.68 SEK -5.19% Intraday chart for Ortoma AB -1.54% -26.86%
23/05 Ortoma AB Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
20/02 Ortoma AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI

Valuation

Fiscal Period: December 2022 2023 2024 2025 2026
Capitalization 1 146.7 371.9 300.4 - -
Enterprise Value (EV) 1 146.7 320.7 248.1 273.4 282.4
P/E ratio -9.37 x -9.55 x 16.2 x -10.1 x -40.5 x
Yield - - - - -
Capitalization / Revenue - 9.75 x 3.41 x 5.09 x 2.42 x
EV / Revenue - 8.41 x 2.82 x 4.63 x 2.27 x
EV / EBITDA - -20.3 x 7.49 x -17.3 x 28.5 x
EV / FCF - -30.3 x 248 x -10.5 x -31.4 x
FCF Yield - -3.3% 0.4% -9.51% -3.19%
Price to Book - - - - -
Nbr of stocks (in thousands) 19,821 35,420 37,084 - -
Reference price 2 7.400 10.50 8.100 8.100 8.100
Announcement Date 20/01/23 20/02/24 - - -
1SEK in Million2SEK
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2022 2023 2024 2025 2026
Net sales 1 - 38.14 88.1 59 124.3
EBITDA 1 - -15.83 33.1 -15.8 9.9
EBIT 1 - -21.98 19.1 -29.8 -4.1
Operating Margin - -57.64% 21.68% -50.51% -3.3%
Earnings before Tax (EBT) 1 - -21.87 18 -31 -7
Net income 1 -15.75 -21.87 18 -31 -7
Net margin - -57.35% 20.43% -52.54% -5.63%
EPS 2 -0.7900 -1.100 0.5000 -0.8000 -0.2000
Free Cash Flow 1 - -10.59 1 -26 -9
FCF margin - -27.76% 1.14% -44.07% -7.24%
FCF Conversion (EBITDA) - - 3.02% - -
FCF Conversion (Net income) - - 5.56% - -
Dividend per Share - - - - -
Announcement Date 20/01/23 20/02/24 - - -
1SEK in Million2SEK
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2023 Q2 2023 Q3 2023 Q4
Net sales 1 25.09 10.3 15.6
EBITDA 1 13.14 -0.627 -24.53
EBIT 1 13.12 -1.9 -29.37
Operating Margin 52.27% -18.44% -188.3%
Earnings before Tax (EBT) - - -
Net income - - -
Net margin - - -
EPS - - -
Dividend per Share - - -
Announcement Date 22/08/23 26/10/23 20/02/24
1SEK in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2022 2023 2024 2025 2026
Net Debt 1 - - - - -
Net Cash position 1 - 51.2 52.3 27 18
Leverage (Debt/EBITDA) - - - - -
Free Cash Flow 1 - -10.6 1 -26 -9
ROE (net income / shareholders' equity) - -15.2% 10% -18% -4%
ROA (Net income/ Total Assets) - - - - -
Assets 1 - - - - -
Book Value Per Share - - - - -
Cash Flow per Share - - - - -
Capex 1 - - - 1 2
Capex / Sales - - - 1.69% 1.61%
Announcement Date 20/01/23 20/02/24 - - -
1SEK in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Ratings for Ortoma AB

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Medical Software & Technology Services

1st Jan change Capi.
ORTOMA AB Stock Ortoma AB
-26.86% 2.89Cr
VEEVA SYSTEMS INC. Stock Veeva Systems Inc.
-3.90% 2.99TCr
PRO MEDICUS LIMITED Stock Pro Medicus Limited
+31.35% 852.33Cr
SECTRA AB Stock Sectra AB
+34.03% 421.04Cr
EVOLENT HEALTH, INC. Stock Evolent Health, Inc.
-29.31% 267.77Cr
VERADIGM INC. Stock Veradigm Inc.
-9.44% 160.35Cr
OMNICELL, INC. Stock Omnicell, Inc.
-20.44% 137.49Cr
LUNIT INC. Stock Lunit Inc.
-34.19% 113.82Cr
SIMULATIONS PLUS, INC. Stock Simulations Plus, Inc.
+4.92% 94Cr
B-SOFT CO.,LTD. Stock B-SOFT Co.,Ltd.
-43.66% 79Cr
Medical Software & Technology Services
  1. Stock Market
  2. Equities
  3. ORT B Stock
  4. Financials Ortoma AB